Aldosterone breakthrough during low-dose combined temocapril and losartan in patients with IgA nephropathy

被引：0
|
作者：
Horita, Yoshio
Taura, Kouichi
Taguchi, Takashi
Furusu, Akira
Kohno, Shigeru
机构：
[1] Natl Nagasaki Med Ctr, Dept Med, Div Nephrol, Nagasaki, Japan
[2] Nagasaki Municipal Med Ctr, Dept Internal Med, Nagasaki, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, Nagasaki 852, Japan
[4] Nagasaki Univ, Grad Sch Biomed Sci, Dept Internal Med, Nagasaki 852, Japan
来源：
JOURNAL OF HYPERTENSION | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [1] Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin a nephropathy
    Horita, Y
    Tadokoro, M
    Taura, K
    Suyama, N
    Taguchi, T
    Miyazaki, M
    Kohno, S
    HYPERTENSION RESEARCH, 2004, 27 (12) : 963 - 970
  • [2] Efficacy and safety of Telitacicept combined with low-dose mycophenolate mofetil in IgA nephropathy
    Hassan, Mohammed Haji Rashid
    Chen, Xinghua
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2029 - I2029
  • [3] Efficacy and safety of Telitacicept combined with low-dose mycophenolate mofetil in IgA nephropathy
    Hassan, Mohammed Haji Rashid
    Chen, Xinghua
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [4] Low-Dose Losartan Therapy Reduces Proteinuria in Normotensive Patients with Immunoglobulin A Nephropathy
    Shimizu, Ari
    Takei, Takashi
    Uchida, Keiko
    Tsuchiya, Ken
    Nitta, Kosaku
    HYPERTENSION RESEARCH, 2008, 31 (09) : 1711 - 1717
  • [5] Low-Dose Losartan Therapy Reduces Proteinuria in Normotensive Patients with Immunoglobulin A Nephropathy
    Ari Shimizu
    Takashi Takei
    Keiko Uchida
    Ken Tsuchiya
    Kosaku Nitta
    Hypertension Research, 2008, 31 : 1711 - 1717
  • [6] ALDOSTERONE BREAKTHROUGH DURING COMBINED ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN II RECEPTOR BLOCKER IN PATIENTS WITH IGA NEPHROPATHY
    Horita, Yoshio
    Tadokoro, Masato
    Taura, Kouichi
    Taguchi, Takashi
    Miyazaki, Masanobu
    Kohno, Shigeru
    NEPHROLOGY, 2005, 10 : A37 - A37
  • [7] Tacrolimus combined with low-dose corticosteroids is an effective and safe therapeutic option for refractory IgA nephropathy
    Wan, Qi-Jun
    Hu, Hao-Fei
    He, Yong-Cheng
    Luan, Shao-Dong
    Chen, Hong-Tao
    Li, Tong
    Xu, Yi
    Xu, Hui-Li
    Liao, Ying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (03) : 1934 - 1938
  • [8] Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy
    Min, Lulin
    Wang, Qin
    Cao, Liou
    Zhou, Wenyan
    Yuan, Jiangzi
    Zhang, Minfang
    Che, Xiajing
    Mou, Shan
    Fang, Wei
    Gu, Leyi
    Zhu, Mingli
    Wang, Ling
    Yu, Zanzhe
    Qian, Jiaqi
    Ni, Zhaohui
    ONCOTARGET, 2017, 8 (29) : 48375 - 48384
  • [9] DIABETIC NEPHROPATHY Aldosterone breakthrough in patients on an ACEI
    Nakagawa, Takahiko
    NATURE REVIEWS NEPHROLOGY, 2010, 6 (04) : 194 - 196
  • [10] Experimental IgA nephropathy induced by a low-dose environmental mycotoxin, nivalenol
    Hinoshita, F
    Suzuki, Y
    Yokoyama, K
    Hara, S
    Yamada, A
    Ogura, Y
    Hashimoto, H
    Tomura, S
    Marumo, F
    Ueno, Y
    NEPHRON, 1997, 75 (04) : 469 - 478
12345